G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 41 NOK 6.22% Market Closed
Market Cap: 632.3m NOK
Have any thoughts about
Gentian Diagnostics ASA?
Write Note

Relative Value

The Relative Value of one GENT stock under the Base Case scenario is 36.19 NOK. Compared to the current market price of 41 NOK, Gentian Diagnostics ASA is Overvalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENT Relative Value
Base Case
36.19 NOK
Overvaluation 12%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
22
Median 3Y
6.2
Median 5Y
7
Industry
2.3
Forward
3.7
vs History
4
vs Industry
Median 3Y
-39.1
Median 5Y
-45.1
Industry
23
Forward
40.2
vs History
23
vs Industry
8
Median 3Y
-24
Median 5Y
-39.2
Industry
14.3
vs History
19
vs Industry
6
Median 3Y
-15
Median 5Y
-26.5
Industry
20
vs History
87
vs Industry
14
Median 3Y
4.2
Median 5Y
4.3
Industry
2.2
vs History
98
vs Industry
21
Median 3Y
5.5
Median 5Y
6.1
Industry
2.4
Forward
3.2
vs History
98
vs Industry
19
Median 3Y
10.9
Median 5Y
16.6
Industry
5
vs History
23
vs Industry
0
Median 3Y
-28.2
Median 5Y
-37.3
Industry
12.9
Forward
23.2
vs History
vs Industry
Median 3Y
-44.5
Median 5Y
-42.3
Industry
17.4
Forward
41.1
vs History
23
vs Industry
10
Median 3Y
-20.9
Median 5Y
-30.8
Industry
14
vs History
19
vs Industry
8
Median 3Y
-14.7
Median 5Y
-24.7
Industry
18.2
vs History
82
vs Industry
10
Median 3Y
5.8
Median 5Y
6.5
Industry
1.9

Multiples Across Competitors

GENT Competitors Multiples
Gentian Diagnostics ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Gentian Diagnostics ASA
OSE:GENT
632.3m NOK 4.3 284.8 60 -13 296
JP
Hoya Corp
TSE:7741
7.1T JPY 8.6 36.2 23.9 28.8
CH
Alcon AG
SIX:ALC
37.7B CHF 4.2 35.7 17.5 33.9
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.4 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.5T KRW 201.6 -56.4 -86.8 -81.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.1B CNY 11.5 27.6 24 24
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.8 56.1
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.2 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.3 47.6 23.2 38.1
P/E Multiple
Earnings Growth PEG
NO
G
Gentian Diagnostics ASA
OSE:GENT
Average P/E: 61.8
284.8
N/A N/A
JP
Hoya Corp
TSE:7741
36.2
15%
2.4
CH
Alcon AG
SIX:ALC
35.7
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.4
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -56.4 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.2
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
G
Gentian Diagnostics ASA
OSE:GENT
Average EV/EBIT: 78.2
Negative Multiple: -13 296
N/A N/A
JP
Hoya Corp
TSE:7741
28.8
N/A N/A
CH
Alcon AG
SIX:ALC
33.9
27%
1.3
DK
Coloplast A/S
CSE:COLO B
26.6
12%
2.2
US
Align Technology Inc
NASDAQ:ALGN
22.1
17%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -81.9 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24
23%
1
US
Lantheus Holdings Inc
NASDAQ:LNTH
12
12%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
56.1
56%
1
UK
ConvaTec Group PLC
LSE:CTEC
462
25%
18.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
38.1
36%
1.1